仁和药业(000650) - 2014 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2014 was ¥411,501,878.28, representing a 3.21% increase compared to ¥398,708,268.54 in the same period last year[8]. - Net profit attributable to shareholders decreased by 29.09% to ¥52,716,299.67 from ¥74,345,887.83 year-on-year[8]. - The net profit after deducting non-recurring gains and losses was ¥51,628,522.23, down 26.37% from ¥70,116,845.18 in the previous year[8]. - Basic and diluted earnings per share fell by 33.5% to ¥0.0532 from ¥0.08 year-on-year[8]. - The weighted average return on equity decreased to 2.85%, down 1.52% from 4.37% in the previous year[8]. Cash Flow and Assets - The net cash flow from operating activities surged by 4,657.81% to ¥44,510,772.35, compared to ¥935,529.94 in the same period last year[8]. - Total assets at the end of the reporting period were ¥2,334,365,802.32, a slight increase of 0.24% from ¥2,328,717,164.66 at the end of the previous year[8]. - Net assets attributable to shareholders increased by 2.44% to ¥1,870,936,277.15 from ¥1,826,424,169.83 at the end of the previous year[8]. - Other receivables increased by 276.83% to ¥43,162,141.35 due to GMP renovation project payments and allocated market funds[15]. - Other current assets decreased by 70.14% to ¥2,283,558.22 due to the offset of input tax to be deducted at the beginning of the year[15]. - Non-current assets decreased by 100% to ¥0 due to the failure to complete the business registration of a subsidiary last year[15]. - Deferred tax liabilities decreased by 100% to ¥0 as a result of a subsidiary merger[15]. Investment and Management - Investment income surged by 306.49% to ¥3,961,722.84 as the company utilized surplus funds for financial management[15]. - Cash received from investment income rose by 706.56% to ¥3,397,331.17, reflecting effective financial management strategies[15]. - Cash paid for the purchase of fixed assets increased by 37.67% to ¥36,803,771.38, primarily due to investments in subsidiary processing workshops[15]. - Management expenses decreased by 61.49% to ¥41,093,201.64, as surplus funds were redirected to financial products generating investment income[15]. Shareholder Information - The total number of shareholders at the end of the reporting period was 52,614[11]. - The largest shareholder, Renhe (Group) Development Co., Ltd., held 44.55% of the shares, totaling 441,253,333 shares[11]. Other Income - Other operating income fell by 75.37% to ¥1,804,420.38, mainly due to delays in receiving government support funds and tax incentives[15]. - Cash received from the disposal of fixed assets increased by 10,782.18% to ¥798,890.00, attributed to payments received from land disposals last year[15].